您的位置: 首页 > 2020年5月 第51卷 第3期 > 文字全文
2023年7月 第38卷 第7期11
目录

经阴道三维容积超声成像在子宫肌瘤FIGO分类的应用价值

Clinical value of transvaginal three-dimensional volumetric ultrasound imaging in the FIGO classification of hysteromyoma

来源期刊: 广州医药 | 70-72 发布时间:2021-11-28 收稿时间:2025/11/13 17:49:10 阅读量:27
作者:
关键词:
超声三维容积成像子宫肌瘤国际妇产科联盟FIGO
UltrasonographyThree-dimensional imagingHysteromyomaFIGO
DOI:
10.3969/j.issn.1000-8535.2020.03.016
收稿时间:
2019-12-20 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨经阴道三维容积超声成像在诊断子宫肌瘤FIGO分类的临床应用价值。方法 对本院收治的手术病理结果证实的219例子宫肌瘤,回顾临床资料分组,99例以经阴道三维容积超声成像作为观察组,120例以经阴道二维彩超检查作为对照组。评估经阴道三维容积超声成像在诊断子宫肌瘤FIGO分类的诊断符合率。结果 两组子宫肌瘤FIGO分类诊断符合率分别为:观察组97.93%,对照组78.33%;经阴道三维容积超声成像检查诊断符合率显著高于二维彩超,差异有统计学意义。结论 经阴道三维容积超声成像较二维彩超能获得更为丰富的诊断信息,诊断子宫肌瘤FIGO分类较二维彩超优势显著,有利于提高诊断准确率,为指导临床个性化治疗提供可靠的理论依据,值得临床推广应用。
Objective To investigate the clinical value of transvaginal three-dimensional volumetric ultrasound imaging in the diagnosis of the FIGO classification of hysteromyoma. Methods To retrospectively analysis data of 219 cases hysteromyoma confirmed by the surgical pathological findings in this hospital. 99 cases treated with transvaginal 3D ultrasound were as the observation group, and 120 cases treated with vaginal 2D ultrasound as the control group. To evaluate the diagnostic coincidence rate of transvaginal three-dimensional volumetric ultrasound imaging in the diagnosis of FIGO classification of hysteromyoma. Results The coincidence rates of FIGO classification of hysteromyoma in the two groups were 97.93% in the observation group and 78.33% in the control group; the diagnostic coincidence rate of transvaginal three-dimensional volumetric ultrasound imaging was higher than that of two-dimensional color Doppler ultrasound, and the difference was statistically significant. Conclusion Transvaginal three-dimensional volumetric ultrasound imaging can obtain richer diagnostic information than two-dimensional color Doppler ultrasound. In the FIGO classification of hysteromyoma, it has significant advantages than two-dimensional color Doppler ultrasound, which is conducive to improving the diagnostic accuracy and providing a reliable theory for guiding clinical personalized treatment. The basis is worthy of clinical promotion and application.
1、 王宏.经阴道彩色多普勒超声诊断子宫肌瘤和子宫腺肌症及腺肌瘤的临床价值分析[J]. 影像研究与医学应用,2019,3(13):238-239. 王宏.经阴道彩色多普勒超声诊断子宫肌瘤和子宫腺肌症及腺肌瘤的临床价值分析[J]. 影像研究与医学应用,2019,3(13):238-239.
2、 子宫肌瘤的诊治中国专家共识专家组.子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志,2017,52(12):793-800. 子宫肌瘤的诊治中国专家共识专家组.子宫肌瘤的诊治中国专家共识[J]. 中华妇产科杂志,2017,52(12):793-800.
3、 简云兰.腹腔镜子宫肌瘤剔除术与开腹子宫肌瘤剔除术后并发症率的分析[J]. 实用妇科内分泌电子杂志,2019,6(18):59-63. 简云兰.腹腔镜子宫肌瘤剔除术与开腹子宫肌瘤剔除术后并发症率的分析[J]. 实用妇科内分泌电子杂志,2019,6(18):59-63.
4、 唐烨.比较腹腔镜子宫肌瘤剔除术与传统开腹子宫肌瘤术治疗子宫肌瘤的临床疗效[J]. 实用妇科内分泌电子杂志,2019,6(2):38-39. 唐烨.比较腹腔镜子宫肌瘤剔除术与传统开腹子宫肌瘤术治疗子宫肌瘤的临床疗效[J]. 实用妇科内分泌电子杂志,2019,6(2):38-39.
5、 MUNRO M G, CRITCHLEY H O, BRODER M S, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age[J]. Int J Gynecol Obstet, 2011,113(1):3-13. MUNRO M G, CRITCHLEY H O, BRODER M S, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age[J]. Int J Gynecol Obstet, 2011,113(1):3-13.
6、 ANDREOTTI R F, FLEISCHER A C.Practical applications of 3D sonography in gynecologic imaging[J]. Radiol Clin North Am, 2014,52(6): 1201-1213. ANDREOTTI R F, FLEISCHER A C.Practical applications of 3D sonography in gynecologic imaging[J]. Radiol Clin North Am, 2014,52(6): 1201-1213.
7、 韩松岩.经阴道三维超声联合二维超声诊断子宫肌瘤的效果观察[J]. 影像研究与医学应用,2019,3(9):203-204. 韩松岩.经阴道三维超声联合二维超声诊断子宫肌瘤的效果观察[J]. 影像研究与医学应用,2019,3(9):203-204.
8、 LUFEE W, NIKKI W, JAYSHREE R, et al. Three-dimensional imaging of the uterus: The value of the coronal plane[J]. World J Radiol, 2015,7(12):484-493. LUFEE W, NIKKI W, JAYSHREE R, et al. Three-dimensional imaging of the uterus: The value of the coronal plane[J]. World J Radiol, 2015,7(12):484-493.
9、 T?R?K P, PóKA R. Diagnosis and treatment of hysteromyoma[J]. Orv Hetil, 2016, 157(21):813-819. T?R?K P, PóKA R. Diagnosis and treatment of hysteromyoma[J]. Orv Hetil, 2016, 157(21):813-819.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录